Patients with autoimmune conditions such as lupus, rheumatoid arthritis or psoriasis face a noticeably higher chance of developing cancer within the first year after their diagnosis. Italian researchers studied more than 356, 000 people and found a 32 % rise in cancer odds during that early period.  

The research shows that the risk is linked to ongoing inflammation, not necessarily the treatments themselves. Once patients begin taking anti‑inflammatory drugs, their likelihood of cancer starts to fall.  

The study highlighted that lung and bladder cancers, blood cancers like leukemia and lymphoma, and melanoma are most common among those with autoimmune diseases.  

Because the danger peaks early, doctors should consider regular cancer screenings for newly diagnosed patients. Taking anti‑inflammatory medication can help lower the elevated risk associated with chronic inflammation.


# Autoimmune Patients Face Elevated Cancer Risk in First Year After Diagnosis

Patients with autoimmune conditions such as **lupus**, **rheumatoid arthritis**, or **psoriasis** experience a markedly higher chance of developing cancer within the first year after their diagnosis. Italian researchers analyzed data from **356,000+ individuals** and found a **32 % increase** in cancer odds during this early period.

> The elevated risk is tied to ongoing inflammation, not necessarily the treatments themselves. Once patients begin taking anti‑inflammatory drugs, their likelihood of cancer starts to fall.

## Most Common Cancers in Autoimmune Patients
- **Lung cancer**  
- **Bladder cancer**  
- **Blood cancers** (leukemia, lymphoma)  
- **Melanoma**

## Clinical Implications
Because the danger peaks early, doctors should consider:
- **Regular cancer screenings** for newly diagnosed patients
- Initiating **anti‑inflammatory medication** to reduce the heightened risk associated with chronic inflammation



Autoimmune Ailments Boost Cancer Chances, But Medicine Helps

Most Common Cancers in Autoimmune Patients

Clinical Implications

Actions